Diamyd Medical Management
Management criteria checks 3/4
Diamyd Medical's CEO is Ulf Hannelius, appointed in Apr 2016, has a tenure of 8.08 years. total yearly compensation is SEK3.01M, comprised of 70.9% salary and 29.1% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth SEK2.51M. The average tenure of the management team and the board of directors is 2.3 years and 20.3 years respectively.
Key information
Ulf Hannelius
Chief executive officer
kr3.0m
Total compensation
CEO salary percentage | 70.9% |
CEO tenure | 8.1yrs |
CEO ownership | 0.2% |
Management average tenure | 2.3yrs |
Board average tenure | 20.3yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Feb 29 2024 | n/a | n/a | -kr120m |
Nov 30 2023 | n/a | n/a | -kr116m |
Aug 31 2023 | kr3m | kr2m | -kr116m |
May 31 2023 | n/a | n/a | -kr119m |
Feb 28 2023 | n/a | n/a | -kr115m |
Nov 30 2022 | n/a | n/a | -kr99m |
Aug 31 2022 | kr3m | kr2m | -kr104m |
May 31 2022 | n/a | n/a | -kr91m |
Feb 28 2022 | n/a | n/a | -kr106m |
Nov 30 2021 | n/a | n/a | -kr83m |
Aug 31 2021 | kr3m | kr2m | kr60m |
May 31 2021 | n/a | n/a | kr74m |
Feb 28 2021 | n/a | n/a | kr99m |
Nov 30 2020 | n/a | n/a | kr121m |
Aug 31 2020 | kr3m | kr2m | kr10m |
May 31 2020 | n/a | n/a | kr13m |
Feb 29 2020 | n/a | n/a | kr13m |
Nov 30 2019 | n/a | n/a | -kr35m |
Aug 31 2019 | kr2m | kr1m | -kr37m |
May 31 2019 | n/a | n/a | -kr38m |
Feb 28 2019 | n/a | n/a | -kr43m |
Nov 30 2018 | n/a | n/a | -kr42m |
Aug 31 2018 | kr2m | kr1m | -kr44m |
May 31 2018 | n/a | n/a | -kr39m |
Feb 28 2018 | n/a | n/a | -kr35m |
Nov 30 2017 | n/a | n/a | -kr32m |
Aug 31 2017 | kr2m | kr906k | -kr26m |
Compensation vs Market: Ulf's total compensation ($USD275.38K) is about average for companies of similar size in the Swedish market ($USD238.92K).
Compensation vs Earnings: Ulf's compensation has increased whilst the company is unprofitable.
CEO
Ulf Hannelius (48 yo)
8.1yrs
Tenure
kr3,006,000
Compensation
Mr. Ulf Hannelius, PhD, MBA, has been the Chief Executive Officer of Diamyd Medical AB (publ) since April 11, 2016 and serves as its President. Mr. Hannelius served as an Interim Chief Executive Officer at...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & President | 8.1yrs | kr3.01m | 0.23% SEK 2.5m | |
Chief Financial Officer | no data | no data | 0.13% SEK 1.5m | |
Chief Operating Officer | 1.9yrs | no data | 0.012% SEK 132.0k | |
Chief Scientific Officer | 6.7yrs | no data | no data | |
Chief Regulatory Affairs Officer | 2.3yrs | no data | 0.0039% SEK 42.3k | |
Chief Medical & Business Officer | 2.3yrs | no data | 0.0093% SEK 100.3k | |
Chief Operating Officer of Manufacturing Site | 1.3yrs | no data | 0.0024% SEK 26.4k |
2.3yrs
Average Tenure
48yo
Average Age
Experienced Management: DMYD BTU B's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Member of the Scientific Advisory Board | 28.3yrs | no data | no data | |
Member of the Scientific Advisory Board | 25.3yrs | no data | no data | |
Member of the Scientific Advisory Board | 28.3yrs | no data | no data | |
Independent Chairman | 28.3yrs | kr1.06m | 3.18% SEK 34.4m | |
Chairman of Scientific Advisory Board & Independent Director | 27.3yrs | kr175.00k | 0.016% SEK 176.9k | |
Independent Director | 3.1yrs | kr125.00k | 0.0097% SEK 105.5k | |
Independent Vice Chairman | 12.3yrs | kr230.00k | 0.057% SEK 620.2k | |
Independent Director | 7.3yrs | kr138.00k | 0.00097% SEK 10.5k | |
Independent Director | 15.3yrs | kr164.00k | 1.33% SEK 14.4m | |
Independent Director | 1.2yrs | kr28.00k | no data |
20.3yrs
Average Tenure
64.5yo
Average Age
Experienced Board: DMYD BTU B's board of directors are seasoned and experienced ( 20.3 years average tenure).